The basis for future personalized therapy approaches – Machine learning-generated 1-year survival rate, metastatic status and therapy-dependent survival in pancreatic cancer patients

The models developed in this study may serve as a foundation for supporting tumor board decisions and demonstrate that personalized, ML-based therapy concepts are feasible in the near future. In addition, the models proposed in this study are helpful for generating ML-based synthetic control arms in future clinical trials.

Authors

Institutions

Publication Details

Journal
European Journal of Cancer
Published
2025-12-17
DOI
https://doi.org/10.1016/j.ejca.2025.116189
Citations
1
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The basis for future personalized therapy approaches – Machine learning-generated 1-year survival rate, metastatic status and therapy-dependent survival in pancreatic cancer patients

Damian Tobias Rieke, Uwe Pelzer, Marcus Bahra, Sebastian Stintzing et al.
1 citations
European Journal of Cancer
Pancreatic and Hepatic Oncology Research
1.05
article

The basis for future personalized therapy approaches – Machine learning-generated 1-year survival rate, metastatic status and therapy-dependent survival in pancreatic cancer patients

Damian Tobias Rieke, Uwe Pelzer, Marcus Bahra, Sebastian Stintzing, Kristina Tschulik, Markus Herbert Lerchbaumer, F Schneider, Matthäus Felsenstein, Gregor Duwe, Mihnea P. Dragomir, Annabel Helga Sophie Alig, Georg Hilfenhaus, Ulrich Keilholz, Christopher Neumann, Richard G. Compton, Haotian Chen, Loredana Vecchione, Ralf-Detlef Kutsche
article en
1 citations

Abstract

The models developed in this study may serve as a foundation for supporting tumor board decisions and demonstrate that personalized, ML-based therapy concepts are feasible in the near future. In addition, the models proposed in this study are helpful for generating ML-based synthetic control arms in future clinical trials.

European Journal of CancerVol. 234
TH Köln - University of Applied Sciences (DE), Johannes Gutenberg University Mainz (DE), Heidelberg University (DE), University of Michigan (US), Humboldt-Universität zu Berlin (DE), University of Oxford (GB), University Medical Center of the Johannes Gutenberg University Mainz (DE), Krankenhaus Waldfriede (DE), Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE), Charité - Universitätsmedizin Berlin (DE), Ruhr University Bochum (DE)
Openalex Percentile: Top 15%
Pancreatic and Hepatic Oncology Research
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.